The UK research reports a blood clot syndrome is occurring after the first dose of the Oxford/AstraZeneca vaccine. The blood clot syndrome carries a high risk of death and can occur in otherwise young and healthy people.
According to AsiaOne, the data of Vaccinated people under 50 by Oxford/AstraZeneca vaccine, blood clots have occurred in 50,000 people. The confirmed probable cases that were presented in the UK hospitals between 22 March and 6 June have been examined for symptoms, signs, and outcomes in 220 people. The consultant hematologist at Oxford University Hospital NHS Foundation Trust and lead author of the analysis Dr. Sue Pavord has published in the New England Journal of Medicine that it is very important to stress that this kind of reaction to the Oxford/AstraZeneca vaccine is very rare. It is also very important for those who do develop blood clots, the results can be devastating. It usually affects the young, otherwise healthy vaccine recipients and high mortality rate.
AsiaOne Magzine reported that the blood clot is particularly dangerous when the patient has a low platelet count and bleeding in the brain. However, the vaccine has lowered the infection rates as per the reports.
